Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 4,308 shares at $116.71 ($503K) on 2025-02-13, disclosed to the SEC on 2025-02-14.
Scheduled sale ($503k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $116.71 | 1,056 | $123K | 24.5% |
| 2 | $116.71 | 1,056 | $123K | 24.5% |
| 3 | $116.74 | 1,098 | $128K | 25.5% |
| 4 | $116.74 | 1,098 | $128K | 25.5% |
| Total | $116.73 avg | 4,308 | $503K | 100% |
| Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |
| NBIX | SELL | 2024-04-17 | $5.3M | — | Filing → |